U.S. markets closed

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.87+0.08 (+0.34%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
Total Revenue
0
0
0
Operating Expense
11,729
4,695
5,009
Operating Income
-11,729
-4,695
-5,009
Net Non Operating Interest Income Expense
-424
-295
76
Other Income Expense
-1,074
-171
-164
Pretax Income
-13,227
-5,161
-5,097
Net Income Common Stockholders
-13,127
-5,061
-5,097
Diluted NI Available to Com Stockholders
-13,127
-5,061
-5,097
Basic EPS
-
0
0
Diluted EPS
-
0
0
Basic Average Shares
-
6,187
6,187
Diluted Average Shares
-
6,187
6,187
Total Operating Income as Reported
-12,033
-5,449
-5,009
Total Expenses
11,729
4,695
5,009
Net Income from Continuing & Discontinued Operation
-13,227
-5,161
-5,097
Normalized Income
-12,467
-5,090
-5,097
Interest Income
52
51
85
Interest Expense
476
346
9
Net Interest Income
-424
-295
76
EBIT
-12,751
-4,815
-5,088
EBITDA
-12,751
-
-
Net Income from Continuing Operation Net Minority Interest
-13,227
-5,161
-5,097
Total Unusual Items Excluding Goodwill
-760
-71
-
Total Unusual Items
-760
-71
-
Normalized EBITDA
-11,991
-4,744
-5,088
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0